Charlie Gourley

24PUBLICATIONS
251CO-AUTHORS
Radiation therapyPredictive and prognostic markersCancer geneticsMolecular targetsPhylogeny and comparative analysis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Dec 11, 2025
Molecular Profiling and Tumor Biomarker Analysis of GOG281/LOGS: A Positive Late-Phase Trial of Trametinib for Recurrent/Persistent Low-Grade Serous Ovarian Carcinoma.

Robert L Hollis, Austin Miller, Heather A Lankes

|Nov 27, 2025
Spectrum and Impact of Mitochondrial DNA Mutations in Ovarian Cancer.

Samantha Su Ping Low, Laura Greaves, Ryan Silk

|Nov 15, 2025
Targeting DNA Damage Repair Pathways Beyond PARP Inhibition.

Eve Merry, Charlie Gourley

|Jul 24, 2025
Oxford Classic-Defined EMT Risk Stratification of High-Grade Serous Ovarian Cancer for Guiding Treatment Decisions.

Lena Rai, Antonella Ravaggi, Eliana Bignotti

|Jul 11, 2025
Efficacy and Safety of Avutometinib ± Defactinib in Recurrent Low-Grade Serous Ovarian Cancer: Primary Analysis of ENGOT-OV60/GOG-3052/RAMP 201.

Susana N Banerjee, Els Van Nieuwenhuysen, Carol Aghajanian

Pageof 4